What Is a Good EBITDA Margin for a Dental Practice?

One percentage point of EBITDA margin on a million-dollar practice is worth roughly $50,000 the day you sell. Most owners will spend a year fighting a $9,000 supply contract and never touch the ten points of margin sitting in their fee schedule.

So here is our thesis, and informed owners are welcome to argue with it: for a general practice running below 25% normalized EBITDA, the margin problem is almost always a pricing and payer-mix problem, not a spending problem. Owners who attack a 19% margin with cost control are treating a structural condition as a housekeeping one. They will get two points back, feel productive, and arrive at their transition conversation with a number that still prices their life's work $600,000 below what they assumed.

The benchmark question matters because EBITDA margin is the one operating number that converts directly into enterprise value. Collections are vanity. Production is theory. Margin is what a buyer multiplies.

The 22% Everyone Quotes Is Not a Margin

Start with the figure that anchors every conversation in this category. ADA Health Policy Institute data puts average general practitioner net income at $215,320 in 2025 against average gross billings of $965,660. That is a net-income-to-billings ratio of about 22%.

Owners hear 22% and assume it is the margin they should be measured against. It is not. That number is the owner's total return for being both the dentist and the business, blended into one line. It includes payment for the crowns they prepped, the molars they sectioned, the eight-hour days they stood through. None of that is profit. It is wages.

EBITDA margin asks a colder question: what does this practice earn after paying somebody market rate to do the clinical work the owner currently does for free in the P&L? That single adjustment is where most owners' self-estimates fall apart.

Normalizing a $1,000,000 Practice Down to 14%

Take a solo GP collecting $1,000,000. The owner pays themselves $300,000 across salary and distributions. After that, the P&L shows $50,000 of profit, which the owner describes to anyone who asks as "about a 5% year, but I take good money out."

Now normalize. Add the $300,000 of owner compensation back, then deduct what it would cost to replace that clinical production. The Bureau of Labor Statistics puts the median annual wage for dentists at $176,110 as of May 2025, which is the government benchmark analysts reach for when they need a defensible market-rate associate cost. Run it: $50,000 plus $300,000 minus $176,110 gives normalized EBITDA of $173,890, or 17.4%.

Except a real associate does not work for a flat median wage. They work on a production percentage. If the owner personally produces $700,000 of that $1,000,000 and the replacement associate takes 30%, the true replacement cost is $210,000. That drops normalized EBITDA to $140,000, a 14% margin.

Same practice. Same collections. Same owner. The margin reads 22%, 17.4%, or 14% depending entirely on which owner-compensation assumption you use. Any owner who cannot state which assumption produced their number does not have a number.

25 to 35 for Solo GPs, and Why Most Land Low

Once the definition is fixed, the bands are reasonably consistent across people who look at a lot of these practices. Dental Transitions holds that a well-run solo general practice should target normalized EBITDA of 30% or higher after adjusting owner compensation to a market-rate associate-equivalent cost. Scott Leune puts healthy general practices at 25% to 35%, specialty at 40% to 50%, and corresponds that general-practice range to total overhead of 60% to 65%, with anything below a 20% margin flagged as a systemic-issue warning.

Patient Prism breaks the same territory out by structure:

• Solo general practice: 25% to 35%
• Multi-doctor general: 22% to 32%
• DSO-affiliated: 18% to 28%
• Multi-location group: 20% to 30%
• Orthodontics: 30% to 45%
• Cosmetic and aesthetic-focused: 28% to 40%

Notice the direction of travel. Adding doctors lowers the band. Adding locations lowers it again. Affiliating lowers it most. Scale in dentistry buys purchasing power and administrative depth, and it spends that advantage on management layers, associate compensation and corporate overhead. Owners who assume consolidation automatically improves margin have the arrow pointing the wrong way. It improves total EBITDA, which is a different thing, and the reason groups buy practices in the first place.

The overhead correspondence is where owners should be most careful. If your overhead report says 62% and you feel comfortable, check whether your own clinical pay sits inside that 62% or outside it. That one accounting choice moves the implied margin by ten points or more. We see more owners misled by their overhead percentage than by any other figure on their monthly report.

1.4% Revenue Against 4.9% Expenses Is Not Drift

Here is the number that should frighten anyone planning a transition in the next five years. Over the prior five-year period, the ADA's data shows practice revenues rose just 1.4% while expenses rose 4.9%. Revenue grew at roughly a quarter of the pace of cost.

That is not a bad quarter. That is a structural gap, and it is the cleanest example of Drift vs. Erosion in the whole industry. Drift is small, steady and recoverable: your supply spend creeps from 6.2% to 6.8% of collections because nobody renegotiated the catalogue, and a disciplined quarter pulls it back. Erosion is structural and compounding: reimbursement rates sit frozen while wages, lab fees and rent climb every single year, and no amount of operational tightening closes it, because the gap is being manufactured upstream by someone else's pricing decision.

A 3.5-point annual spread between cost growth and revenue growth compounds into roughly 18 points of margin over five years on a practice with no pricing power. That is the entire difference between a saleable practice and a job with a mortgage attached. Treating erosion as drift is the expensive mistake, and it is the default mistake, because drift has obvious homework and erosion requires an uncomfortable conversation with a payer.

What Most Owners Get Wrong: Counting Your Own Paycheck as Profit

The specific error, and we see it most often in owners 18 to 36 months from a sale who have never been through a transition: they count their own compensation as margin, then feel betrayed when the buyer's quality-of-earnings work hands it back.

It is an honest mistake with a clear cause. The P&L a CPA builds is optimized for the tax return, not for valuation. It is engineered to move as much money as possible through the owner's compensation and benefits, which is correct tax practice and completely useless as a margin benchmark. The owner reads "net income," sees a healthy figure, divides by collections and gets something in the twenties. Then a buyer deducts a market-rate associate cost, and the twenties become the teens.

The second version of the same error: owners who do buy the right diagnosis and then apply the wrong treatment. They discover they are at 19%, accept that 19% is a problem, and respond with a supplies audit, a lab vendor change, and a hard look at a hygienist's hours. Our view: that sequence is backwards. If your margin shortfall came from the expense side, cost work fixes it. If it came from frozen fees on a payer mix that is now 70% of your schedule, cost work cannot fix it, and you will spend 18 months proving that at the cost of your staff's goodwill.

Two Practices, Same $1.2M, $780,000 Apart at Sale

Two solo GPs, both collecting $1,200,000, both with one doctor and five operatories.

Practice A runs a 19% normalized EBITDA margin, which is $228,000. Practice B runs 32%, which is $384,000. The annual gap is $156,000.

Decompose that gap, and the composition is the whole lesson. Practice B's blended collection realization runs 6 points higher on the same production, worth $72,000. Staff cost runs 25% of collections against Practice A's 30%, worth $60,000. Supplies run 6% against 8%, worth $24,000. Total: $156,000.

The single largest contributor is what they get paid per procedure, not what they spend per procedure. And the supply line, the one most owners attack first, is the smallest of the three at $24,000, roughly 15% of the gap.

Now price it. Use a working multiple of 5x normalized EBITDA for a solo practice of this size, and understand that your real multiple will depend on your market, your payer mix, your hygiene percentage and your lease. On that assumption, Practice A sells for $1,140,000 and Practice B for $1,920,000. A $780,000 difference in enterprise value on identical collections.

Every point of margin on this practice is worth about $60,000 at exit. That is what the supplies conversation is competing against.

Ortho at 40% Is Not a Better Business, It Is a Different One

General practice owners who see orthodontics at 30% to 45% and cosmetic work at 28% to 40% sometimes read those bands as a scoreboard they are losing on. They are not comparable. Those margins reflect different chair-time economics, different lab and material ratios, and crucially a different relationship with third-party payers. A fee-for-service aligner case and a PPO-contracted crown are not the same business model wearing different coats.

The usable signal is directional: the practices sitting in the highest margin bands are the ones with the most control over their own pricing. That holds across every category in the data. Margin tracks pricing authority. It does not track thrift.

What We'd Do at 19%

If we were handed a general practice at 19% normalized EBITDA, we would not open with a supplies audit. We would pull the top five payers by collections, calculate the realized rate per procedure against the full fee for each, and identify which contracts have gone three or more years without a meaningful increase. Then we would renegotiate the worst one, and if the answer is no, we would plan the exit from that plan over the following 12 months. We wouldn't touch the staffing model until that work is done, because cutting clinical capacity to fix a pricing problem shrinks the practice twice.

What we're tracking next: whether the DSO-affiliated band holds at the bottom of its 18% range or breaks below it, because that floor is what sets the price for every owner negotiating with a group buyer. What would change our mind: a credible cohort of general practices closing a six-point margin gap through expense discipline alone, with the payer mix held constant. We have not seen it. If it exists, we want the numbers.

Three Numbers to Pull Before Friday

Pull your trailing twelve months of collections, your owner compensation including every benefit and distribution, and your personal production as a share of total production. Recalculate net income with your own clinical pay replaced by a 30% associate cost on your production, then divide by collections. That is your real number, and it is the only one a buyer will use. If it lands below 25%, spend next week on your five largest payer contracts rather than your vendor list.

If you want to see where your normalized margin puts your practice's value against the 25% to 35% band, run your own numbers through our free valuation calculator. It does the owner-compensation adjustment properly, so you get the margin a buyer would compute rather than the one your tax return implies.